Effects of Early Statin Treatment After Acute Myocardial Infarction (AMI) in Japanese Patients
Myocardial Infarction
About this trial
This is an interventional prevention trial for Myocardial Infarction focused on measuring randomized prospective study, lipid-lowering therapy with any available statins, multicenter study, Japanese, acute myocardial infarction, primary percutaneous coronary intervention
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of acute myocardial infarction Serum total cholesterol levels on admission ranges ≥180 mg/dL and <240 mg/dL Exclusion Criteria: Age < 18 years Time from symptom onset to admission > 96 hours Use of lipid-lowering agents within the previous 3 months Known familial dyslipidemia Severe renal failure Known hepatic disease Signs and symptoms of severe heart failure (Killip class III or IV) A scheduled PCI or coronary artery bypass grafting (CABG) A history of previous PCI (within 6 months) or CABG (within 3 months) The presence of malignant disease The presence of allergy to statins.
Sites / Locations
- Department of Cardiovascular Medicine, Kumamoto University Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
Statins
No statins